Literature DB >> 9557824

Polycystic ovary syndrome: anomalies in progesterone production.

N Doldi1, A Gessi, A Destefani, F Calzi, A Ferrari.   

Abstract

The underlying cause of anovulation and miscarriage in polycystic ovary syndrome (PCOS) is unknown. Progesterone may play an important role in oocyte fertilization and embryo implantation. Therefore, in this study we analyse the endocrine function of luteinizing granulosa cells to synthesize progesterone in vivo and in vitro in PCOS and normal patients participating in an in-vitro fertilization programme. Human luteinizing granulosa cells were obtained from 10 patients with normal ovaries (controls) and 10 patients with PCOS by follicular aspiration of individual follicles of each patient and pooled in an attempt to obtain three groups: cells from follicle sizes < or =10,>10< or =15 and > or =16. Serum concentrations of oestradiol and progesterone on the day of human chorionic gonadotrophin (HCG) injection were significantly higher (P < 0.01 and P < 0.05) in PCOS patients than in controls. After HCG stimulation, in-vitro progesterone production was enhanced in granulosa cells of the control group and concentrations increased with follicular size as expected. However, the concentration of progesterone of PCOS patients did not increase with follicular size and there was a significant difference between normal and PCOS groups in follicles >10< or =15 mm (P < 0.05) and > or =16 mm (P < 0.01). Oestradiol production was increased in follicles > or =16 mm in both groups, although this did not reach significance. In summary, it seems that PCOS granulosa cells demonstrate an abnormal capacity to synthesize progesterone in vivo and in vitro. The understanding of granulosa cell function in PCOS may explain the anovulation and miscarriage that occurs in these patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557824     DOI: 10.1093/humrep/13.2.290

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

Review 1.  Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  J Mol Endocrinol       Date:  2018-10-16       Impact factor: 5.098

2.  The effect of metformin treatment in vivo on acute and long-term energy metabolism and progesterone production in vitro by granulosa cells from women with polycystic ovary syndrome.

Authors:  D Maruthini; S E Harris; J H Barth; A H Balen; B K Campbell; H M Picton
Journal:  Hum Reprod       Date:  2014-08-19       Impact factor: 6.918

3.  Pregnancy rate following luteal phase support in Iranian women with polycystic ovarian syndrome.

Authors:  Fatemeh Foroozanfard; Hamidreza Saberi; Seyed Alireza Moraveji; Fatemeh Bazarganipour
Journal:  Int J Fertil Steril       Date:  2014-11-01

Review 4.  Relationship between Advanced Glycation End Products and Steroidogenesis in PCOS.

Authors:  Deepika Garg; Zaher Merhi
Journal:  Reprod Biol Endocrinol       Date:  2016-10-21       Impact factor: 5.211

5.  Ultra-low Doses of Follicle Stimulating Hormone and Progesterone Attenuate the Severity of Polycystic Ovary Syndrome Features in a Hyperandrogenized Mouse Model.

Authors:  Irene Tessaro; Silvia Modina; Valentina Lodde; Giulia Sivelli; Federica Franciosi; Laura Terzaghi; Patrizia Luchini; Cristiano Rumio; Alberto Maria Luciano
Journal:  J Reprod Infertil       Date:  2017 Jul-Sep

6.  Comparison of a progestin-primed ovarian stimulation protocol with a flexible GnRH antagonist protocol in patients with polycystic ovary syndrome who are participating in an IVF programme: study protocol for a randomised controlled trial.

Authors:  Ningling Wang; Qianqian Zhu; Meng Ma; Zhou Liang; Yu Tao; Yun Wang; Yanping Kuang
Journal:  BMJ Open       Date:  2020-12-02       Impact factor: 2.692

Review 7.  A review on the mechanisms of the effect of silymarin in milk thistle (Silybum marianum) on some laboratory animals.

Authors:  Roshanak Khazaei; Alireza Seidavi; Mehrdad Bouyeh
Journal:  Vet Med Sci       Date:  2021-10-02

8.  The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments.

Authors:  Xiuxian Zhu; Hongjuan Ye; Yonglun Fu
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.